A therapeutic mixture comprised of L-arginine and angiogenic growth factors is disclosed for the treatment of diseases related to endothelial dysfunction.

Uma mistura therapeutic compreendida da L-arginina e de fatores angiogenic do crescimento é divulgada para o tratamento das doenças relacionadas ao dysfunction endothelial.

 
Web www.patentalert.com

< (none)

< 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5H)-furanone as a cox-2 inhibitor

> Bridged tap terminator

> (none)

~ 00007